Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PyL PET/CT in High Risk and Recurrent Prostate Cancer
NCT04700332Phase 2Recruiting
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Feb 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by Hoag Memorial Hospital Presbyterian. Started Feb 2021; status: recruiting.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04700332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700332.